Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | CA12 | O43570 | 1/20 | 0.32 |
| ▸ | CA9 | Q16790 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30404381 | 0.89 | NPC1 (0.33) | NPC1RAB9ACA12CA9 | |
| SCHEMBL24174584 | 0.89 | NPC1 (0.33) | NPC1RAB9ACA12CA9 | |
| SCHEMBL30404481 | 0.88 | NPC1 (0.33) | NPC1RAB9ACA12CA9 | |
| SCHEMBL24174587 | 0.88 | NPC1 (0.33) | NPC1RAB9ACA12CA9 | |
| SCHEMBL30404253 | 0.85 | MAPT (0.39) | NPC1RAB9ACA12CA9 | |
| SCHEMBL24174599 | 0.85 | MAPT (0.39) | NPC1RAB9ACA12CA9 | |
| SCHEMBL30404013 | 0.85 | NPC1 (0.33) | NPC1RAB9ACA12CA9 | |
| SCHEMBL25350859 | 0.85 | NPC1 (0.33) | NPC1RAB9ACA12CA9 | |
| SCHEMBL24170315 | 0.84 | CA1 (0.36) | NPC1RAB9ACA12CA9 | |
| SCHEMBL24175247 | 0.84 | HDAC1 (0.36) | NPC1RAB9ACA12CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230247994-A1 | HETEROCYCLENE DERIVATIVES AS PEST CONTROL AGENTS | BAYER AKTIENGESELLSCHAFT (DE) | 2023-08-10 | — | — | US | disclosed |
| US-20230247994-A1 | HETEROCYCLENE DERIVATIVES AS PEST CONTROL AGENTS | BAYER AKTIENGESELLSCHAFT (DE) | 2023-08-10 | — | — | US | disclosed |
| US-20230247994-A1 | HETEROCYCLENE DERIVATIVES AS PEST CONTROL AGENTS | BAYER AKTIENGESELLSCHAFT (DE) | 2023-08-10 | — | — | US | disclosed |
| EP-4175961-A1 | HETEROCYCLENE DERIVATIVES AS PEST CONTROL AGENTS | Bayer Aktiengesellschaft (DE) | 2023-05-10 | — | — | EP | disclosed |
| WO-2022002818-A1 | HETEROCYCLENE DERIVATIVES AS PEST CONTROL AGENTS | BAYER AKTIENGESELLSCHAFT (DE) | 2022-01-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230247994-A1 | HETEROCYCLENE DERIVATIVES AS PEST CONTROL AGENTS | CHRM1, DDT, H1-0 | NPC1 2771/4885RAB9A 217/4885CA12 4410/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.